13F HOLDINGS REPORT
Essex Woodlands Management, Inc.
Quarter ended Q4 2024 · Filed February 13, 2025 · Accession 0000908834-25-000074
Total Value
$433.2M
Positions
7
Other Managers
0
Confidential Omitted
No
Holdings (7)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | MIMEDX GROUP, INC. | MDXG | 28,195,249 | $271.2M | 62.61% |
| 2 | BIOVENTUS | BVS | 13,021,324 | $136.7M | 31.56% |
| 3 | TELA BIO, INC. | TELA | 4,110,709 | $12.4M | 2.87% |
| 4 | EYEPOINT PHARMACEUTICALS INC | EYPT | 1,169,857 | $8.7M | 2.01% |
| 5 | MEDICINOVA INC | MNOV | 1,105,941 | $2.3M | 0.54% |
| 6 | REVANCE THERAPEUTICS INC | 761330109 | 457,085 | $1.4M | 0.32% |
| 7 | VENUS CONCEPT, INC. | VERO | 1,089,190 | $413,892 | 0.10% |